CIK 0001326190
- Non-accelerated filer
- Smaller reporting company
Altimmune, Inc.
Sign in to watch- Ticker
- ALT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 202726770
- Phone
- +1 862-457-1450
- Business address
- 350 MOUNT KEMBLE AVENUE, SUITE 1001, MORRISTOWN, NJ, 07960
- Former names
- PHARMATHENE, INC, HEALTHCARE ACQUISITION CORP
- Open-market buys, last 90 days
- $82,244
- in 3 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$82,244. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2016-09-15 | GILL JOHN President and CEO | Option exercise | +20,000 | $1.45 | $29K | 652,244 |
| 2016-09-15 | GILL JOHN President and CEO | Option exercise | +20,000 | $1.64 | $33K | 672,244 |
| 2016-09-15 | GILL JOHN President and CEO | Option exercise | +20,000 | $1.51 | $30K | 692,244 |
| 2016-09-15 | GILL JOHN President and CEO | Option exercise · Employee Stock Option (right to buy) | −20,000 | 0 | ||
| 2016-09-15 | GILL JOHN President and CEO | Option exercise · Employee Stock Option (right to buy) | −20,000 | 0 | ||
| 2016-09-15 | GILL JOHN President and CEO | Option exercise · Employee Stock Option (right to buy) | −20,000 | 0 | ||
| 2016-09-15 | GILL JOHN President and CEO | Option exercise · Employee Stock Option (right to buy) | −20,000 | 0 | ||
| 2016-06-01 | St Peter Steven Director | Grant or award · Stock option (right to buy) | +20,000 | $2.20 | $44K | 20,000 |
| 2016-06-01 | SAYARE MITCHEL Director | Grant or award · Stock option (right to buy) | +20,000 | $2.20 | $44K | 20,000 |
| 2016-06-01 | GILL JOHN President and CEO | Grant or award · Stock option (right to buy) | +100,000 | $2.20 | $220K | 100,000 |
| 2016-06-01 | Runge Jeffrey W. Director | Grant or award · Stock option (right to buy) | +20,000 | $2.20 | $44K | 20,000 |
| 2016-06-01 | RICHMAN ERIC I Director | Grant or award · Stock option (right to buy) | +20,000 | $2.20 | $44K | 20,000 |
| 2016-06-01 | SCHAFFER DERACE L Director | Grant or award · Stock option (right to buy) | +20,000 | $2.20 | $44K | 20,000 |
| 2016-04-13 | RICHMAN ERIC I Director | Option exercise | +13,233 | $1.76 | $23K | 190,055 |
| 2016-04-13 | RICHMAN ERIC I Director | Sale | −13,233 | $2.20 | $29K | 176,822 |
| 2016-04-13 | RICHMAN ERIC I Director | Option exercise | +150,000 | $1.16 | $174K | 326,822 |
| 2016-04-13 | RICHMAN ERIC I Director | Sale | −150,000 | $2.20 | $330K | 176,822 |
| 2016-04-13 | RICHMAN ERIC I Director | Option exercise | +91,121 | $1.16 | $106K | 267,943 |
| 2016-04-13 | RICHMAN ERIC I Director | Sale | −91,121 | $2.20 | $200K | 176,822 |
| 2016-04-13 | RICHMAN ERIC I Director | Option exercise | +75,000 | $1.19 | $89K | 251,822 |
Page 39 of 43 · 845 trades